Close Menu

Making a Mark

Nearly half the late-stage clinical trials sponsored by a US National Cancer Institute program have influenced patient care, a new analysis has found.

Researchers led by Fred Hutchinson Cancer Research Center's Joseph Unger analyzed the effects of 182 trials in which the SWOG Cancer Research Network participated between January 1980 and June 2017. The SWOG Cancer Research Network is part of NCI's Clinical Trial Network (NCTN), which aims to identify new cancer treatments.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

A tissue sample from the 1960s harbors a near-complete sample of HIV, IFLScience reports.

A new bill would reshape the US National Science Foundation to include a focus on technological development, according to Science.

The Food and Drug Administration's decision to halt a SARS-CoV-2 study has drawn criticism, according to Stat News.

In Genome Biology this week: features affecting gut microbiome and parasite patterns, cellular interactions in lung tumor microenvironment, and more.